General Information
Version
2.1
Revision date
2023-03-21
Product name
Softaskin pure foam
supplier name
B. Braun Medical AG
Manufacturer Name
B. Braun Medical AG
Emergency telephone
+49 - (0) 6132 - 84463
Icons in SDS
Company Information
company name
B. Braun Medical AG
e-mail address of the competent person responsible for the Safety Data Sheet
info.bbmch@bbraun.com, medinfo.bbmuk@bbraun.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Classification according to GHS
CLP Regulation Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
Highly flammable liquid and vapour. Causes serious eye damage. May cause drowsiness or dizziness.
2.2 Label elements
Labelling according to GB CLP Regulation
Hazard pictograms
GHS07 GHS07
Signal word
Warning : Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear eye protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents and container to an approved waste disposal plant.
Additional information
Applies for those countries where this product is classified as cosmetic; as ready for use cosmetic, this product is not subject to labelling obligation according to the CE directives in these countries. Labelling according to: exemption for packages of a capacity of 125ml or less : Applies for those countries where this product is classified as cosmetic; as ready for use cosmetic, this product is not subject to labelling obligation according to the CE directives in these countries.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII